Beryl Drugs Limited (BOM:524606)

Beryl Drugs Revenue

Beryl Drugs had revenue of 75.66M INR in the quarter ending June 30, 2026, with 57.82% growth. This brings the company's revenue in the last twelve months to 215.51M, up 9.44% year-over-year. In the fiscal year ending March 31, 2026, Beryl Drugs had annual revenue of 188.20M, down -11.00%.

• Revenue (ttm): 215.51M
• Revenue Growth: +9.44%
• P/S Ratio: 0.54
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 116.65M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	188.20M	-23.26M	-11.00%
Mar 31, 2025	211.46M	-55.83M	-20.89%
Mar 31, 2024	267.30M	-1.41M	-0.53%
Mar 31, 2023	268.71M	122.67M	84.00%
Mar 31, 2022	146.04M	5.11M	3.62%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error